Friday, February 26, 2021
Corporate Compliance Insights
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Articles
    • See All Articles
    • NEW: COVID-Related
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Leadership and Career
  • Vendor News
  • Jobs
    • Compliance & Risk
    • Information Security
  • Events
    • Webinars & Events
    • Submit an Event
  • Downloads
    • eBooks
    • Whitepapers
  • Podcasts
  • Videos
  • Subscribe
No Result
View All Result
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Articles
    • See All Articles
    • NEW: COVID-Related
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Leadership and Career
  • Vendor News
  • Jobs
    • Compliance & Risk
    • Information Security
  • Events
    • Webinars & Events
    • Submit an Event
  • Downloads
    • eBooks
    • Whitepapers
  • Podcasts
  • Videos
  • Subscribe
No Result
View All Result
Corporate Compliance Insights
Home Compliance

Compliance in Health Care: What Providers Need to Know About the DOJ’s New Guidance

How Updates to “Evaluation of Corporate Compliance Programs” Will Impact Health Care Organizations

by Ty Howard
June 26, 2019
in Compliance, Featured
doctor in scrubs holding virtual checklist

Compliance is near the top of nearly every health care provider’s list of priorities. But what does a robust compliance program really look like? Ty Howard, Partner at Bradley Arant Boult Cummings, offers insight from the DOJ’s recently updated guidance.

On April 30, 2019, the Department of Justice (DOJ) Criminal Division released a new guidance document intended to assist prosecutors in evaluating corporat­­­e compliance programs and guide corporations in creating them. Updating a similar prior version from 2017, the new guidance provides an important roadmap for businesses drafting new or reviewing and updating existing compliance plans.

Background for DOJ Action

Several DOJ documents already inform how prosecutors and courts assess a corporation’s compliance program, including the DOJ’s Justice Manual section on “Principles of Federal Prosecution of Business Organizations,” the October 2018 memorandum from Assistant Attorney General Benczkowski entitled, “Selection of Monitors in Criminal Division Matters,” and several other sources. Beyond the DOJ, of course, myriad sources of compliance guidance and best practices exist, particularly in the health care industry. As the DOJ is often the ultimate judge of a compliance program in a civil or criminal enforcement action, the new guidance is an important addition to this body of compliance evaluation tools.

In brief, this newest guidance further elaborates on the aspects of an effective compliance program, organizing itself around three “fundamental questions” a prosecutor should ask in evaluating a corporate compliance program:

  1. “Is the corporation’s compliance program well designed?”
  2. “Is the program being applied earnestly and in good faith?” and
  3. “Does the corporation’s compliance program work?”

The guidance provides detailed analysis and checklists prosecutors might consider with respect to each question and in each case.

The guidance is neither binding law on corporations, nor a “rigid formula” that prosecutors must follow. But it does reveal design and implementation elements that create a strong corporate compliance program in the eyes of the DOJ — critical information for highly regulated industries like health care.

Practical Recommendations

Health care companies should use the guidance to evaluate their own compliance programs and efforts to date. Among the highlights from the new guidance:

  1. Companies should tailor their compliance programs to their business and unique risk areas. In this respect, the guidance notes that the “starting point for a prosecutor’s evaluation” of a compliance program is to “understand the company’s business from a commercial perspective; how the company has identified, assessed and defined its risk profile; and the degree to which the program devotes appropriate scrutiny and resources to the spectrum of risks.”
  2. Companies should develop and maintain a culture of compliance. In this respect, the DOJ considers whether the compliance program is “accessible and applicable to all company employees” and incorporated into day-to-day operations. Tone at the top remains a key consideration, as the guidance recognizes that a “company’s top leaders – the board of directors and executives – set the tone for the rest of the company.”
  3. Companies should have effective implementation and evaluation measures. “Paper programs” or programs that are never updated will not pass muster.
  4. Other keys include confidential reporting to foster a workplace free of retaliation; due diligence on third parties like vendors and acquisition targets; and regular tracking monitoring, and measurement of compliance issues.

Overall, this new guidance provides helpful insight to the DOJ’s view of compliance issues and sets a high bar for corporations and officers. Health care companies should review it closely and consider such compliance efforts as preventative medicine in their efforts to avoid costly administrative, civil and even criminal enforcement actions.


Tags: DOJhealth caretone at the top
Previous Post

How Can Regulators Leverage Monitors?

Next Post

Aviation Contractors Could Face Fewer Whistleblower Lawsuits Thanks to Legal and Regulatory Shifts

Ty Howard

Ty E. Howard is a partner at Bradley Arant Boult Cummings LLP and chair of the firm’s Government Enforcement and Investigations Practice Group. A former state and federal prosecutor, he defends and counsels businesses and individuals involved in government investigations, compliance matters, False Claims Act and whistleblower cases, related business litigation and white-collar criminal matters. He represents health care clients in all industry sectors and regularly counsels clients on FCA, fraud and abuse and health care-specific compliance issues. He can be reached at thoward@bradley.com.

Related Posts

woman looking at horizon from mountain top

What’s on the Horizon for Anti-Corruption Enforcement?

February 25, 2021
cannabis leaf on $100 bill

The Intersection of EDD and Banking Cannabis

February 24, 2021
gold cup award on red background with stars

Ethisphere Announces the 2021 World’s Most Ethical Companies

February 23, 2021
illustration of hand holding flashlight illuminating hidden stairs

The Corporate Transparency Act: Pulling Back the Veil

February 23, 2021
Next Post
underside of plane on tarmac

Aviation Contractors Could Face Fewer Whistleblower Lawsuits Thanks to Legal and Regulatory Shifts

Access realtime data
Addressing systemic racism in the workplace SAI Global
Dynamic Risk Assessments with Workiva
Top 10 Risk and Compliance Trends

Special Coverage

Special COVID page graphic

Jump to a Topic:

anti-corruption anti-money laundering/AML Artificial Intelligence/A.I. automation banks board of directors board risk oversight bribery CCPA/California Consumer Privacy Act Cloud Compliance communications management Coronavirus/COVID-19 corporate culture crisis management cyber crime cyber risk data analytics data breach data governance decision-making diversity DOJ due diligence fcpa enforcement actions financial crime GDPR GRC HIPAA information security KYC/know your customer machine learning monitoring ransomware regtech reputation risk risk assessment Sanctions SEC social media risk supply chain technology third party risk management tone at the top training whistleblowing
No Result
View All Result

Privacy Policy

Follow Us

  • Facebook
  • Twitter
  • LinkedIn
  • RSS Feed

Category

  • CCI Press
  • Compliance
  • Compliance Podcasts
  • Cybersecurity
  • Data Privacy
  • eBooks
  • Ethics
  • FCPA
  • Featured
  • Financial Services
  • Fraud
  • Governance
  • GRC Vendor News
  • HR Compliance
  • Internal Audit
  • Leadership and Career
  • Opinion
  • Resource Library
  • Risk
  • Uncategorized
  • Videos
  • Webinars
  • Whitepapers

© 2019 Corporate Compliance Insights

No Result
View All Result
  • Home
  • About
  • Articles
  • Vendor News
  • Podcasts
  • Videos
  • Whitepapers
  • eBooks
  • Events
  • Jobs
  • Subscribe

© 2019 Corporate Compliance Insights